First published · Last updated
Integrating nitrosamine theoretical formation into Translational Pharmaceutics: Mitigating risks during accelerated formulation development in early phase clinical studies
Journal article describing integration of theoretical nitrosamine formation into translational pharmaceutics to mitigate risks during accelerated formulation development in early-phase clinical studies. Published by Elsevier BV on 2026-09-01.
Categories: science-and-space, public-health, technology
Generated scores
Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.
- Confidence
- 5/10
- Geographic reach
- 1/10
- Global importance
- 3/10
- Impact magnitude
- 3/10
- Positivity
- 7/10
- Urgency
- 2/10
Why it matters
Addresses mitigation of nitrosamine-formation risks during early-phase drug formulation, relevant to clinical development safety.

